Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCash Due from BankCommon EquityFed Funds SoldGoodwillGoodwill & IntangiblesIntangiblesInterest DepositsLiabilities and Shareholders EquityLoans - GrossLoans - Loss AllowanceLoans - NetLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current DebtOther Non-Current AssetsPayablesPreferred SharesProperty, Plant & Equipment (Net)Receivables - AccuredRetained EarningsSecurities - TradableShareholder's EquityTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Broadway Financial (BYFC) Cash & Equivalents (2016 - 2025)

Broadway Financial has reported Cash & Equivalents over the past 11 years, most recently at $10.5 million for Q4 2025.

  • Quarterly results put Cash & Equivalents at $10.5 million for Q4 2025, down 82.88% from a year ago — trailing twelve months through Dec 2025 was $10.5 million (down 82.88% YoY), and the annual figure for FY2025 was $10.5 million, down 82.88%.
  • Cash & Equivalents for Q4 2025 was $10.5 million at Broadway Financial, down from $19.7 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for BYFC hit a ceiling of $280.1 million in Q2 2022 and a floor of $10.5 million in Q4 2025.
  • Median Cash & Equivalents over the past 5 years was $64.2 million (2024), compared with a mean of $94.1 million.
  • Biggest five-year swings in Cash & Equivalents: tumbled 96.17% in 2023 and later surged 745.12% in 2024.
  • Broadway Financial's Cash & Equivalents stood at $231.5 million in 2021, then plummeted by 93.04% to $16.1 million in 2022, then skyrocketed by 553.18% to $105.2 million in 2023, then plummeted by 41.67% to $61.4 million in 2024, then tumbled by 82.88% to $10.5 million in 2025.
  • The last three reported values for Cash & Equivalents were $10.5 million (Q4 2025), $19.7 million (Q3 2025), and $29.5 million (Q2 2025) per Business Quant data.